PubRank

Ilan Ziv

Author PubWeight™ 21.30‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The mystery of motor asymmetry in Parkinson's disease. Lancet Neurol 2006 1.55
2 18F-ML-10, a PET tracer for apoptosis: first human study. J Nucl Med 2011 1.26
3 Mutant and wild-type alpha-synuclein interact with mitochondrial cytochrome C oxidase. J Mol Neurosci 2002 1.25
4 From the Gla domain to a novel small-molecule detector of apoptosis. Cell Res 2009 1.19
5 Molecular imaging of cell death in vivo by a novel small molecule probe. Apoptosis 2006 1.05
6 Assessment of response of brain metastases to radiotherapy by PET imaging of apoptosis with ¹⁸F-ML-10. Eur J Nucl Med Mol Imaging 2012 1.03
7 Small-molecule biomarkers for clinical PET imaging of apoptosis. J Nucl Med 2010 0.99
8 Anti-semaphorin 3A antibodies rescue retinal ganglion cells from cell death following optic nerve axotomy. J Biol Chem 2002 0.96
9 Targeting cell death in vivo in experimental traumatic brain injury by a novel molecular probe. J Neurotrauma 2008 0.95
10 Molecular imaging of neurovascular cell death in experimental cerebral stroke by PET. J Nucl Med 2008 0.94
11 Monitoring of tumor response to chemotherapy in vivo by a novel small-molecule detector of apoptosis. Apoptosis 2009 0.93
12 ApoSense: a novel technology for functional molecular imaging of cell death in models of acute renal tubular necrosis. Eur J Nucl Med Mol Imaging 2005 0.89
13 Novel molecular imaging of cell death in experimental cerebral stroke. Brain Res 2007 0.87
14 Management of motor complications in advanced Parkinson's disease. Mov Disord 2007 0.81
15 Patient and caregiver perceptions of the social impact of advanced Parkinson's disease and dyskinesias. J Neural Transm (Vienna) 2012 0.81
16 Use of a single [123I]-FP-CIT SPECT to predict the severity of clinical symptoms of Parkinson disease. Neurol Sci 2009 0.80
17 Monitoring of chemotherapy-induced cell death in melanoma tumors by N,N'-Didansyl-L-cystine. Technol Cancer Res Treat 2007 0.79
18 Autoimmune polyendocrine syndrome type I and brain calcinosis. Parkinsonism Relat Disord 2009 0.78
19 The molecular mechanisms of dopamine toxicity. Adv Neurol 2003 0.78
20 Novel fluorescence molecular imaging of chemotherapy-induced intestinal apoptosis. J Biomed Opt 2009 0.77
21 Residual striatal dopaminergic nerve terminals in very long-standing Parkinson's disease: a single photon emission computed tomography imaging study. Mov Disord 2010 0.76
22 Effect of dopamine agonists on fatigue and somnolence in Parkinson's disease. Mov Disord 2006 0.75
23 Riluzole, an inhibitor of glutamatergic transmission, suppresses levodopa-induced rotations in 6-hydroxydopamine-lesioned rats. Pharmacol Toxicol 2003 0.75
24 Editorial: apoptosis in the aging brain. Apoptosis 2010 0.75
25 Molecular imaging of neurodegeneration by a novel cross-disease biomarker. Exp Neurol 2009 0.75
26 123I-FP-CIT SPECT imaging of dopamine transporters in patients with recurrent sudden falls: are such falls a distinct entity? J Nucl Med Technol 2007 0.75